Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A blocking peptide from human DDAH2.
Synthetic
(Accession #: NP_039268) The DDAH2 Blocking Peptide is derived from Synthetic. The DDAH2 Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-103881 |
| Réf. fabricant | 18271351 |
| Gene ID (Entrez) | 23564 |
| Espèces | Human |
| Numéro d’adhésion | O95865 |
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
| Formule | Lyophilized from sterile distilled water. |
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-58859. This Synthetic Peptide is Designed for Use in an Antibody Competition Assay with Its Corresponding Antibody. Use of This Product in Any Other Assay Has Not Yet Been Tested. For Further Blocking Peptide Related Protocol, Click Here . |
| Alias de gène | DDAHII, dimethylargininase-2, dimethylarginine dimethylaminohydrolase 2G6a, dimethylarginine dimethylaminohydrolase II, EC 3.5.3.18, G6a, N(G), N(G)-dimethylarginine dimethylaminohydrolase 2, NG30, NG-dimethylarginine dimethylamino hydrolase homolog, S-phase protein |
| Symbole de gène(s) | DDAH2 |
| Poids moléculaire | 31kDa |
| Type de produit | DDAH2 |
| Quantité | 100 μg |
| État réglementaire | RUO - research use only |
| Consigne | Blocking Peptide fo th N terminal of protein |
